Table 2.
Univariable Analyses | Multivariable Analyses | ||||
---|---|---|---|---|---|
Characteristic | Statistic | Hazard Ratio (95% CI) | P | Hazard Ratio (95% CI) | P |
Age/Decade | 1.02 (1.01, 1.03) | .002 | |||
Male vs. Female Sex | 0.84 (0.65, 1.09) | .19 | |||
Smoking Status | .15 | ||||
Current smoker | Reference | ||||
Former smoker | 0.80 (0.60, 1.05) | ||||
Never smoker | 1.01 (0.76, 1.36) | ||||
Missing | 0.75 (0.46–1.20) | ||||
Charlson Comorbidity Index, Continuous | 1.08 (1.03, 1.13) | <.001 | |||
Histology | .014 | .013 | |||
TCC | Reference | Reference | |||
TCC with variants | 1.04 (0.70, 1.55) | 1.16 (0.78, 1.72) | |||
Variant | 1.58 (1.16, 2.16) | 1.49 (1.09, 2.04) | |||
Missing | 0.60 (0.28–1.28) | 0.48 (0.23, 1.02) | |||
Pathologic T Stage | <.001 | <.001 | |||
<2 | Reference | Reference | |||
2 | 2.15 (1.38–3.34) | 1.74 (1.12, 2.72) | |||
3, 4 | 4.22 (2.88–6.18) | 3.48 (2.37, 5.13) | |||
Pathologic N Stage | <.001 | ||||
0 | Reference | ||||
1 | 1.27 (0.93–1.73) | ||||
2–3 | 1.74 (1.34–2.26) | ||||
Positive vs. Negative Surgical Margins | 2.34 (1.76–3.09) | .018 | 1.78 (1.33, 2.36) | <.001 | |
Number of Lymph Nodes Removed | .023 | ||||
0 | Reference | ||||
1–9 | 0.74 (0.38–1.48) | ||||
≥10 | 0.60 (0.31–1.17) | ||||
Missing | 1.05 (0.49–2.27) | ||||
Perioperative Chemotherapy, Yes vs. No | 0.48 (0.38, 0.60) | <.001 | 0.47 (0.38, 0.60) | <.001 |
Abbreviation: TCC = transitional-cell carcinoma.